Germline polymorphism of cancer susceptibility genes in gynecologic cancer

被引:15
作者
Ueda, Masatsugu [1 ]
Toji, Eisaku [1 ]
Nunobiki, Osamu [1 ]
Izuma, Shinji [1 ]
Okamoto, Yoshiaki [1 ]
Torii, Kiyo [1 ]
Noda, Sadamu [1 ]
机构
[1] Osaka Canc Prevent & Detect Ctr, Joto Ku, Osaka 5368588, Japan
关键词
FAS; CD95; glutathione-S-transferase; gynecologic cancer; p53; polymorphism;
D O I
10.1111/j.1749-0774.2008.00058.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The multifactorial process of carcinogenesis involves mutations in oncogenes, or tumor suppressor genes, as well as the influence of environmental etiological factors. Common DNA polymorphisms in low penetrance genes have emerged as genetic factors that seem to modulate an individual's susceptibility to malignancy. Genetic studies, which lead to a true association, are expected to increase understanding of the pathogenesis of each malignancy and to be a powerful tool for prevention and prognosis in the future. Here, we review the findings of genetic association studies of gene polymorphisms in gynecologic cancer with special reference to glutathione-S-transferase, FAS/CD95 and p53 genes including our recent research results.
引用
收藏
页码:95 / 104
页数:10
相关论文
共 84 条
[71]  
TEW KD, 1994, CANCER RES, V54, P4313
[72]  
Tsigris C, 2007, ANTICANCER RES, V27, P3577
[73]   Fas gene promoter-670 polymorphism in gynecological cancer [J].
Ueda, M ;
Terai, Y ;
Kanda, K ;
Kanemura, M ;
Takehara, M ;
Yamaguchi, H ;
Nishiyama, K ;
Yasuda, M ;
Ueki, M .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :179-182
[74]   Germline polymorphism of p53 codon 72 in gynecological cancer [J].
Ueda, M ;
Terai, Y ;
Kanda, K ;
Kanemura, M ;
Takehara, M ;
Yamaguchi, H ;
Nishiyama, K ;
Yasuda, M ;
Ueki, M .
GYNECOLOGIC ONCOLOGY, 2006, 100 (01) :173-178
[75]   Fas gene promoter-670 polymorphism (A/G) is associated with cervical carcinogenesis [J].
Ueda, M ;
Hung, YC ;
Terai, Y ;
Yamaguchi, H ;
Saito, J ;
Nunobiki, O ;
Noda, S ;
Ueki, M .
GYNECOLOGIC ONCOLOGY, 2005, 98 (01) :129-133
[76]   Glutathione-S-trans ferase and p53 polymorphisms in cervical carcinogenesis [J].
Ueda, M ;
Hung, YC ;
Terai, Y ;
Saito, J ;
Nunobiki, O ;
Noda, S ;
Ueki, M .
GYNECOLOGIC ONCOLOGY, 2005, 96 (03) :736-740
[77]   Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells. [J].
Masatsugu Ueda ;
Yao-Ching Hung ;
Yoshito Terai ;
Koji Kanda ;
Mikio Takehara ;
Hikari Yamashita ;
Hiroyuki Yamaguchi ;
Daisuke Akise ;
Masayuki Yasuda ;
Koji Nishiyama ;
Minoru Ueki .
Human Cell, 2003, 16 (4) :241-251
[78]  
Wang LH, 2000, HAEMATOLOGICA, V85, P573
[79]   Effect of the codon 7 2 polymorphism (c.215 > C, p.Arg7 2Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma [J].
Wang, Y ;
Kringen, P ;
Kristensen, GB ;
Holm, R ;
Baekelandt, MMO ;
Olivier, M ;
Skomedal, H ;
Hainaut, P ;
Tropé, CG ;
Abeler, VM ;
Nesland, JM ;
Borresen-Dale, A ;
Helland, Å .
HUMAN MUTATION, 2004, 24 (01) :21-34
[80]   THETA-CLASS GLUTATHIONE-S-TRANSFERASE GSTT1 GENOTYPES AND SUSCEPTIBILITY TO CERVICAL NEOPLASIA - INTERACTIONS WITH GSTM1, CYP2D6 AND SMOKING [J].
WARWICK, A ;
SARHANIS, P ;
REDMAN, C ;
PEMBLE, S ;
TAYLOR, JB ;
KETTERER, B ;
JONES, P ;
ALLDERSEA, J ;
GILFORD, J ;
YENGI, L ;
FRYER, A ;
STRANGE, RC .
CARCINOGENESIS, 1994, 15 (12) :2841-2845